Cite

HARVARD Citation

    de Greef, R. et al. (2017). Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma. CPT: pharmacometrics & systems pharmacology. pp. 5-7. [Online]. 
  
Back to record